Serial Number | 98865586 |
Word Mark | MOLECULATOR |
Filing Date | Thursday, November 21, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Wednesday, May 21, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | (Based on Use in Commerce) Manufacturing of enantiopure pharmaceuticals and chemicals for the purpose of reducing human side effects of compounds sold |
Goods and Services | (Based on Intent to Use) Device for separating chiral molecules from racemic solutions to create enantiopure chemicals for use in the pharmaceutical, amino acid, small molecule, nutrition, skin and haircare, pesticide, and food preservative industries |
International Class | 007 - Machines and machine tools; motors and engines (except for land vehicles); machine coupling and transmission components (except for land vehicles); agricultural implements other than hand-operated; incubators for eggs. |
US Class Codes | 013, 019, 021, 023, 024, 031, 034, 035 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 21, 2024 |
Primary Code | 007 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 21, 2024 |
Primary Code | 040 |
First Use Anywhere Date | Sunday, June 30, 2024 |
First Use In Commerce Date | Sunday, June 30, 2024 |
Party Name | CMS Biotechnologies, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Belmore, NY 11710 |
Event Date | Event Description |
Thursday, November 21, 2024 | NEW APPLICATION ENTERED |
Saturday, April 26, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, May 14, 2025 | ASSIGNED TO EXAMINER |
Wednesday, May 21, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, May 21, 2025 | NON-FINAL ACTION E-MAILED |
Wednesday, May 21, 2025 | NON-FINAL ACTION WRITTEN |